303 related articles for article (PubMed ID: 8973548)
61. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P
Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579
[TBL] [Abstract][Full Text] [Related]
62. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ
Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747
[TBL] [Abstract][Full Text] [Related]
63. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin.
de Lannoy IA; Silverman M
Biochem Biophys Res Commun; 1992 Nov; 189(1):551-7. PubMed ID: 1360207
[TBL] [Abstract][Full Text] [Related]
64. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
Stein WD; Cardarelli C; Pastan I; Gottesman MM
Mol Pharmacol; 1994 Apr; 45(4):763-72. PubMed ID: 7910372
[TBL] [Abstract][Full Text] [Related]
65. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.
Yang CP; DePinho SG; Greenberger LM; Arceci RJ; Horwitz SB
J Biol Chem; 1989 Jan; 264(2):782-8. PubMed ID: 2562956
[TBL] [Abstract][Full Text] [Related]
66. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.
Martin C; Higgins CF; Callaghan R
Biochemistry; 2001 Dec; 40(51):15733-42. PubMed ID: 11747450
[TBL] [Abstract][Full Text] [Related]
67. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
68. Characterization of prenylcysteines that interact with P-glycoprotein and inhibit drug transport in tumor cells.
Zhang L; Sachs CW; Fu HW; Fine RL; Casey PJ
J Biol Chem; 1995 Sep; 270(39):22859-65. PubMed ID: 7559420
[TBL] [Abstract][Full Text] [Related]
69. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin.
Pouliot JF; L'Heureux F; Liu Z; Prichard RK; Georges E
Biochem Pharmacol; 1997 Jan; 53(1):17-25. PubMed ID: 8960059
[TBL] [Abstract][Full Text] [Related]
70. Characterization of two pharmacophores on the multidrug transporter P-glycoprotein.
Garrigues A; Loiseau N; Delaforge M; Ferté J; Garrigos M; André F; Orlowski S
Mol Pharmacol; 2002 Dec; 62(6):1288-98. PubMed ID: 12435795
[TBL] [Abstract][Full Text] [Related]
71. P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.
Declèves X; Chappey O; Boval B; Niel E; Scherrmann JM
Pharm Res; 1998 May; 15(5):712-8. PubMed ID: 9619779
[TBL] [Abstract][Full Text] [Related]
72. Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides.
Liu R; Siemiarczuk A; Sharom FJ
Biochemistry; 2000 Dec; 39(48):14927-38. PubMed ID: 11101309
[TBL] [Abstract][Full Text] [Related]
73. Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D.
Loe DW; Sharom FJ
Biochim Biophys Acta; 1994 Feb; 1190(1):72-84. PubMed ID: 7509193
[TBL] [Abstract][Full Text] [Related]
74. The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.
Romsicki Y; Sharom FJ
Eur J Biochem; 1998 Aug; 256(1):170-8. PubMed ID: 9746361
[TBL] [Abstract][Full Text] [Related]
75. Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Biochim Biophys Acta; 2000 Aug; 1481(1):63-74. PubMed ID: 10962093
[TBL] [Abstract][Full Text] [Related]
76. Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers.
Castro AF; Horton JK; Vanoye CG; Altenberg GA
Biochem Pharmacol; 1999 Dec; 58(11):1723-33. PubMed ID: 10571246
[TBL] [Abstract][Full Text] [Related]
77. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.
Safa AR; Stern RK; Choi K; Agresti M; Tamai I; Mehta ND; Roninson IB
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7225-9. PubMed ID: 1976255
[TBL] [Abstract][Full Text] [Related]
78. Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine.
Riffkin CD; Chung R; Wall DM; Zalcberg JR; Cowman AF; Foley M; Tilley L
Biochem Pharmacol; 1996 Nov; 52(10):1545-52. PubMed ID: 8937469
[TBL] [Abstract][Full Text] [Related]
79. RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance.
Perez-Victorias FJ; Conseil G; Munoz-Martinez F; Perez-Victoria JM; Dayan G; Marsaud V; Castanys S; Gamarro F; Renoir JM; Di Pietro A
Cell Mol Life Sci; 2003 Mar; 60(3):526-35. PubMed ID: 12737312
[TBL] [Abstract][Full Text] [Related]
80. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
